ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Enveric Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.39+0.01 (+0.72%)
Close on Oct 19, 2026
- Market cap
- $5.54M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Oct 28, 2025 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Jan 29, 2025 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Jan 27, 2025 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Aug 12, 2022(first seen in filings) | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Jul 15, 2022 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Dec 31, 2020 | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |
| Dec 31, 2019 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Nov 25, 2019 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |